Beam Therapeutics, Inc. (BEAM)
28.34
-1.42
(-4.77%)
USD |
NASDAQ |
Aug 24, 16:00
28.46
+0.12
(+0.42%)
After-Hours: 20:00
Beam Therapeutics Net Income (Quarterly) : -122.68M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -122.68M |
| March 31, 2026 | -94.32M |
| December 31, 2025 | 244.30M |
| September 30, 2025 | -112.73M |
| June 30, 2025 | -102.14M |
| March 31, 2025 | -108.33M |
| December 31, 2024 | -90.35M |
| September 30, 2024 | -96.67M |
| June 30, 2024 | -91.05M |
| March 31, 2024 | -98.67M |
| December 31, 2023 | 142.80M |
| September 30, 2023 | -96.09M |
| June 30, 2023 | -82.78M |
| March 31, 2023 | -96.46M |
| December 31, 2022 | -38.35M |
| September 30, 2022 | -109.58M |
| Date | Value |
|---|---|
| June 30, 2022 | -71.95M |
| March 31, 2022 | -69.21M |
| December 31, 2021 | -64.71M |
| September 30, 2021 | -28.12M |
| June 30, 2021 | -76.25M |
| March 31, 2021 | -201.56M |
| December 31, 2020 | -95.46M |
| September 30, 2020 | -34.45M |
| June 30, 2020 | -34.22M |
| March 31, 2020 | -30.46M |
| December 31, 2019 | -27.85M |
| September 30, 2019 | -19.00M |
| June 30, 2019 | -17.86M |
| March 31, 2019 | -13.61M |
| December 31, 2018 | -25.19M |
| September 30, 2018 | -71.15M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Twist Bioscience Corp. | -35.05M |
| Prime Medicine, Inc. | -42.11M |
| Intellia Therapeutics, Inc. | -106.63M |
| Sana Biotechnology, Inc. | -63.64M |
| Cartesian Therapeutics, Inc. | 13.72M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.49M |
| Total Expenses (Quarterly) | 123.17M |
| EPS Diluted (Quarterly) | -1.176 |
| Enterprise Value | 2.168B |
| Gross Profit Margin (Quarterly) | -1.00K% |
| Profit Margin (Quarterly) | -25.04K% |
| Earnings Yield | -3.03% |
| Normalized Earnings Yield | -2.992 |